BLISSGVSNSEBliss GVS Pharma Limited· PharmaceuticalsLowNeutral
Announced Mon, 15 Sept · 17:23 IST

Bliss GVS Pharma Limited has informed the Exchange regarding allotment of 39950 securities pursuant to ESOP/ESPS at its meeting held on September 15, 2025

Capital Market Events View source PDF

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Bliss GVS Pharma Limited has allotted 39,950 securities to employees under its Employee Stock Option Plan (ESOP) or Employee Stock Purchase Scheme (ESPS). The allotment was approved at a board meeting held on September 15, 2025. This is a routine corporate action related to employee benefit schemes. The number of shares allotted is relatively small, suggesting limited dilution for existing shareholders. The company has informed the stock exchange about this allotment as required under listing rules.

Likely market impact

Minor dilution for existing shareholders due to the small ESOP/ESPS allotment. This is a routine employee benefit event and is unlikely to have a significant impact on the stock price. It may slightly increase the share count going forward.